Diabetes

Maturity-onset diabetes of the young is a rare form of diabetes caused by a range of genetic mutations that interrupt beta cell function.

Researchers compare once-daily injection of degludec and liraglutide versus once-daily injection of glargine.

Pharmacists should be aware of the latest drug trend report from the nation's largest pharmacy benefits manager to better inform patients of any shifts in pricing.

One of the most under-recognized and under-addressed barriers to safe and effective care is low vision.

Susan Cornell, PharmD, CDE, FAPhA, FAADE, offers tips for how pharmacists can monitor for hypoglycemia in type 2 diabetics on second-line therapies.

Pharmacists should keep an eye out for patients with diabetes taking pravastatin and paroxetine concomitantly, as this medication combination could be deadly.

Susan Cornell, PharmD, CDE, FAPhA, FAADE, outlines some strategies for pharmacists tasked with selecting the most appropriate second-line therapy for their patients with type 2 diabetes.

Obese patients who are able to lose 5% of their bodyweight may lower their risk for type 2 diabetes.

Susan Cornell, PharmD, CDE, FAPhA, FAADE, describes the risks for ketoacidosis and serious urinary tract infection associated with use of SGLT2 inhibitors.

Susan Cornell, PharmD, CDE, FAPhA, FAADE, discusses the contraindications and adverse effects pharmacists should consider when recommending antidiabetic agents.

Jennifer Costello, PharmD, BCPS, BC-ADM, discusses several new and emerging therapies for type 2 diabetes and glycemic control.

Pharmacists can positively influence the primary care management of diabetes.

While diabetes is a growing national health threat, it's especially prevalent in Mississippi, where 1 in 8 residents are diabetic.

Fixed-ratio combination of basal insulin glargine 1and GLP-1 receptor agonist lixisenatide shpws promise in adults with type 2 diabetes.

Susan Cornell, PharmD, CDE, FAPhA, FAADE forecasts the future landscape for antidiabetic agents recommended as a second-line treatment for type 2 diabetics.

Susan Cornell, PharmD, CDE, FAPhA, FAADE discusses the patient counseling points pharmacists should be aware of for antidiabetic agents.

Susan Cornell, PharmD, CDE, FAPhA, FAADE outlines the classes of antidiabetic agents recommended as a second-line treatment for type 2 diabetics.

Verapamil shows promise for patients with type 1 diabetes or type 2 diabetes and damaged beta cells.

Drugs like Viagra could improve insulin sensitivity and secretion without diminishing fibrinolytic function.

Diabetes drug liraglutide may cause insulin-producing beta cells to deteriorate.

Erectile dysfunction drugs may improve insulin sensitivity and secretion in patients with prediabetes.

The FDA has accepted for review Sanofi's new drug application for its fixed-ratio combination of basal insulin glargine 100 units/mL and lixisenatide for the treatment of type 2 diabetes.

Diabetes and other conditions are also influenced by a person’s height.

Diabetes is a complex autoimmune condition that requires many treatment and education strategies to achieve health goals beyond glycemic control.

Type 1 diabetes is an autoimmune disease in which the beta cells of the pancreas are destroyed and are unable to produce an adequate amount of the hormone insulin.